Psychedelic Educational Platform Launches Integration Therapy Survey Study to Promote Harm Reduction
A new platform is aimed at psychedelic experience integration and harm reduction by surveying practitioners and patients.
A new platform is aimed at psychedelic experience integration and harm reduction by surveying practitioners and patients.
The University of Alabama at Birmingham is the latest to announce it will begin research into psychedelics.
A shop in Berlin run by a man who claims to be related to former U.S. President Donald Trump, is legally selling an LSD analog.
The Multidisciplinary Association for Psychedelic Studies has been studying mental health treatment for more than 35 years. Here’s what to know.
Texas Gov. Greg Abbott signed a bill requiring the state to study the risks and benefits of psychedelics for veterans suffering with PTSD.
This week in psychedelic business news: Patent progress for biosynthetic psilocybin, psychedelics for brain health, and psychedelic and cannabis companies team up in the name of research.
Ketamine may offer new hope for sufferers of treatment resistant depression via an extended-release oral administered option.
Psychedelic biotech company PharmaTher says its ketamine patch could help relieve depression better than other treatments.
Mydecine Innovations Group says it has found 40 new compounds in at least 25 types of mushrooms with psychedelic and potentially therapeutic properties.
Is synthetic psilocybin as effective as the real thing? A new study looks at the risks and benefits of taking this lab-made psychedelic.
End of content
End of content
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.